Orthofix Medical Inc. provided earnings guidance for the year 2022. For the year, the company expects net sales to be in the range of $475.0 million to $490.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.87 USD | +2.39% |
|
+2.06% | -4.53% |
06-18 | Orthofix Medical Inc. Appoints Aviva Mcpherron as President of Global Operations and Quality | CI |
06-11 | Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.53% | 483M | |
-3.19% | 105B | |
-4.14% | 67.55B | |
+15.49% | 46.71B | |
-6.00% | 46.39B | |
+4.68% | 40.93B | |
+22.10% | 31.63B | |
+11.62% | 24.28B | |
-8.53% | 23.46B | |
-12.33% | 21.95B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Provides Earnings Guidance for the Year 2022